CZD Share Price

Open 0.10 Change Price %
High 0.10 1 Day 0.00 0.00
Low 0.09 1 Week 0.00 0.00
Close 0.09 1 Month 0.00 0.00
Volume 296898 1 Year 0.00 0.00
52 Week High 0.10
52 Week Low 0.03
CZD Important Levels
Resistance 2 0.10
Resistance 1 0.10
Pivot 0.09
Support 1 0.08
Support 2 0.08
ASX Australia Most Active Stocks
AGO 0.05 0.00%
AGO 0.05 0.00%
AGO 0.05 0.00%
VXR 0.01 0.00%
MOD 0.04 0.00%
MOD 0.04 0.00%
TLS 4.84 -0.21%
TLS 4.84 -0.21%
TLS 4.84 -0.21%
BUR 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
GBZ 0.02 100.00%
TMX 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
PYC 0.04 33.33%
GME 0.09 28.57%
GME 0.09 28.57%
More..
ASX Australia Top Losers Stocks
NSE 0.00 -100.00%
NSE 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
SER 0.01 -50.00%
SER 0.01 -50.00%
More..

Calzada Ltd (ASX: CZD)

CZD Technical Analysis 3
As on 28th Nov 2014 CZD Share Price closed @ 0.09 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.10 & Sell for SHORT-TERM with Stoploss of 0.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
CZD Target for February
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
CZD Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.metabolic.com.au
CZD Address
CZD
2/320 Lorimer Street
Port Melbourne, VIC 3207
Australia
Phone: 61 3 8681 4050
Fax: 61 3 8681 4099
CZD Latest News
PolyNovo to introduce BTM into the US   NEWS.com.au   - 03rd Oct 16
PolyNovo' FDA approval for regenerative medical device has further upside   Proactive Investors Australia   - 04th Jan 16
PolyNovo wins US FDA approval for burns treatment NovoSorb   The Australian   - 30th Dec 15
What is Happening to the PolyNovo Share Price?   Daily Reckoning - Australian Edition   - 17th Nov 15
PolyNovo awarded contract to prove burn treatment viability   Proactive Investors Australia   - 29th Sep 15
PolyNovo discusses pathway to market at Proactive Luncheons   Proactive Investors Australia   - 04th Sep 15
Calzada looks to divest Metabolic Pharmaceuticals stake   Proactive Investors Australia   - 21st Nov 14
Nanotechnology in Victoria, Australia: Market Report   AZoNano.com   - 07th Jun 13
BRIEF-Polynovo appoints Gavin Smith as interim CFO   Reuters   - 02nd May 13
We've the brains but not the managers   Sydney Morning Herald   - 10th Jul 05
Interactive Technical Analysis Chart Calzada Ltd ( CZD ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Calzada Ltd
CZD Business Profile
Calzada Limited, through its subsidiaries, focuses on developing medical devices for reconstructive surgery and tissue repair incorporating its patented biodegradable polymer technology NovoSorb. Its NovoPore dressing is used for topical negative pressure therapy in the treatment of chronic wounds, such as pressure sores. The company is also developing dermal replacement wound treatment device using the NovoSorb biodegradable temporizing matrix. In addition, it owns AOD9604, a 16 amino acid peptide based on a fragment of the C-terminus end of human growth hormone, which has applications in the treatment of obesity, bone, cartilage, and muscle diseases and repair. Calzada Limited is based in Port Melbourne, Australia.